Literature DB >> 1623244

Amyloid, dementia and Alzheimer's disease.

B T Hyman1, R E Tanzi.   

Abstract

Senile plaques (SP) and neurofibrillary tangles (NFT) are the major histopathological changes that occur in Alzheimer's disease (AD). How these two different types of lesions are related to each other and to the dementia of AD is unknown. Recent studies lead to paradoxical conclusions: NFT and neuronal alterations such as synapse loss are much more closely related to the symptoms of dementia than are SP. However, mutations in the beta-amyloid protein of SP have been found in some patients with familial AD, suggesting that an abnormality in amyloid causes the development of SP, NFT and AD dementia. Examination of transgenic animals that produce amyloid precursor protein (APP), or altered forms of APP, may lead to the development of an animal model of AD, and ultimately to answers that link amyloid production to neuronal alterations, and cognitive impairments.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623244

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN: 0951-7383


  10 in total

1.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease.

Authors:  R B Knowles; C Wyart; S V Buldyrev; L Cruz; B Urbanc; M E Hasselmo; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Diana H Thyssen; Suzanne E Hickman; Joseph El Khoury; Brian J Bacskai
Journal:  Intravital       Date:  2013-04-01

3.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

4.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

Authors:  B T Hyman; H L West; G W Rebeck; S V Buldyrev; R N Mantegna; M Ukleja; S Havlin; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

5.  The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.

Authors:  R A Armstrong; D Myers; C U Smith
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.

Authors:  Jiao-Ning Shen; Deng-Shun Wang; Rui Wang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

7.  The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis".

Authors:  R A Armstrong
Journal:  Int J Alzheimers Dis       Date:  2011-02-07

8.  Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.

Authors:  Guiquan Chen; Karen S Chen; Dione Kobayashi; Robin Barbour; Ruth Motter; Dora Games; Stephen J Martin; Richard G M Morris
Journal:  J Neurosci       Date:  2007-03-07       Impact factor: 6.167

9.  Selective Regional Loss of Cortical Synapses Lacking Presynaptic Mitochondria in the 5xFAD Mouse Model.

Authors:  Na-Young Seo; Gyu Hyun Kim; Jeong Eun Noh; Ji Won Shin; Chan Hee Lee; Kea Joo Lee
Journal:  Front Neuroanat       Date:  2021-06-25       Impact factor: 3.856

10.  The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods.

Authors:  Dana L Tudorascu; Davneet S Minhas; Patrick J Lao; Tobey J Betthauser; Zheming Yu; Charles M Laymon; Brian J Lopresti; Chet A Mathis; William E Klunk; Benjamin L Handen; Bradley T Christian; Ann D Cohen
Journal:  Alzheimers Dement (Amst)       Date:  2018-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.